VX-702 is a second-generation, orally active mitogen-activated protein kinase (MAPK) p38 inhibitor. It is being tested for the potential treatment of inflammation, rheumatoid arthritis and cardiovascular diseases. Solubility: Soluble in DMSO. Storage and Stability: May be stored at RT for short-term only. Long-term storage is recommended at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
404.32
Purity:
~99%
Form:
Supplied as a white powder.
CAS Number:
[745833-23-2]
* VAT and and shipping costs not included. Errors and price changes excepted
